Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Losartan in fear extinction
NCT03396523Unknown
- Sponsor
- University of Electronic Science and Technology of China
- Start
- Jan 2018
- Primary completion
- Oct 2018
- Modality
- Small Molecules
- Countries
- 1
01
Overview
Randomised, double-blind trial of losartan in post-traumatic stress disorder (PTSD) and anxiety disorder, sponsored by University of Electronic Science and Technology of China. Primary endpoint: Neural activity during fear extinction at 1 hour. Status: unknown.
02
Drugs
losartan
03
Conditions
post-traumatic stress disorder (PTSD)anxiety disorder
Beyond the preview
Go deeper on NCT03396523.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NCT03396523.